Leveraging the Heterogeneity of Adaptative Immune cells Within the Tumor-Ecosystem to Better Describe Clear Cell Renal Cell Carcinoma Biologically and Clinically – Beyond the Abstract
Previous
Previous
Dr. Ferrall-Fairbanks and the BEAT Cancer Lab highlighted in 2022 CrossLink on Cancer
Next
Next